They may recommend adjusting your dose, temporarily pausing treatment, or switching to an alternative medication if the symptom is significantly affecting your quality of life
The gastrointestinal side effects commonly reported with oral berberine (including diarrhoea, constipation, and abdominal discomfort) are often cited as reasons to seek alternative delivery methods, but switching to an unproven transdermal product is not a scientifically justified solution
Although gastrointestinal adverse events such as nausea, vomiting, and diarrhea were more frequent with tirzepatide, the overall findings suggest that dual GIP/GLP-1 receptor agonism may offer clinically meaningful renal advantages over selective GLP-1 receptor agonism alone
Topiramate, an anticonvulsant approved for weight reduction in combination products, is sometimes considered alongside GLP-1 drugs like Ozempic (semaglutide)